Author Archives: Giovanni Ciavarra

Graphical Illustration of the Difference Between Genetic Susceptibility and Predisposition [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, one of the panels focused primarily on communicating genomic issues to juries and judges, including extensive slides and comments from Magna Legal on communicating the concepts of genetic predisposition and “susceptibility” to cancer, where the defense often seeks to make genetic predisposition arguments and plaintiffs often […]

Genomic Causation Analyses for Claims Involving Environmental Pollution, Pathogen Tracking and Cancer Clusters [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, panelists presented examples of results in “environmental cases” in which genomic analyses was used to provide objective evidence to trace sources of exposure and dispersal, and uses of genomic analyses for cancer cluster cases. The panel provided the perspective that genomics are well-suited to the injuries […]

The Process of Using Genomic Analysis in Cases AKA: The nuts and bolts of processes, time and costs [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, Michael Zapata III and Leonel van Zyl, PhD provided an in depth review and analysis of the nuts and bolts for using genomic analysis in legal cases. Michael and Dr. van Zyl explained their systematic and gated methodology for helping clients considering whether a genomic approach […]

Use of Genomics in Medical Cases (Birth Defects, Malpractice, Drugs) [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, panelists addressed the use of genomics in medical cases (birth defects, malpractice, drugs). The panel was composed of an attorney, a medical doctor, and a genetic scientist. Dr. van Zyl, the genetic scientist, provided insightful information as to why individual genetic variability matters, including for Absorption, […]

Case-Specific Results in Benzene (Blood Cancer) and Mesothelioma Cases [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, Kirk Hartley, Esq. chaired the first panel addressing the use of genomics in product liability and/or premises cases involving exposures to toxicants, including asbestos, benzene and radiation. Individual panelists provided summaries of cases they worked on involving genomics. Specifically, Kirk Hartley discussed the results from genetic […]

Webinar: Legal and Policy Considerations in the Use of New Approach Methodologies in Chemical Risk Assessment, Kirk Hartley Presents at ASCCT [Download Presentation]

On Tuesday April 27, Kirk Hartley of ToxicoGenomica presented a webinar hosted by the American Society for Cellular and Computational Toxicology (ASCCT). The topic was: Legal and Policy Considerations in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment. A recording of the webinar can be accessed here and a complimentary copy of […]

Legal and Ethical Challenges in Young Mesothelioma Cases

It is unusual when a younger person (e.g. under age 50) develops a cancer or other disease or condition that might take their life. In some instances, those situations result in lawsuits involving claims that the cancer or other disease was caused by exposure to a “toxin.” Some of the many issues that may arise […]